CNS Disorders | The roles of NQO1 in CNS disorders | Experimental conditions | Methodologies | References | |||
---|---|---|---|---|---|---|---|
AD | Protective role against oxidative stress and inflammation | Regulation of genes involved in apoptosis | Aggregation kinetics of Aβ 1–42 | Promotion of amyloid aggregation | Experimental studies (Human, rats, mouse tissues) Cell culture studies (B16,SH-SY5Y cells, glial cells, pyramidal cells) | Molecular biology, Histopathology, Immunohistochemistry, Behavioral assessments, Biochemical analysis | [72, 116,117,118,119,120,121,122,123,124,125,126,127,128,129,130] |
PD | Protective effect on dopaminergic neurons | Prevent cell death, and modulate neurotrophin receptor affinity in PD | Impaired function of DJ-1 can lead to impairment of NQO1 function | Protect against neurotoxicity induced by MPTP | Experimental studies (Human, mouse tissues) Cell culture studies (Dopamine cells, CATH, SK-N-BE(2)C cells) | Molecular biology, Histopathology, Immunohistochemistry | [41, 131,132,133,134,135,136,137,138,139,140,141,142,143,144,145,146,147,148,149,150,151,152,153,154,155,156] |
MS | NQO1 expression is upregulated in active and chronic active MS lesions | NQO1 and Nrf2 levels may be useful as biomarkers | Nrf2 inducers TFM-735, dimethyl fumarate, sulforaphane, and myricetin | Upregulation of NQO1 effects of dimethyl fumarate in the EAE model of MS | Experimental studies (Human, mouse tissues) Cell culture studies (Human primary cells, human brain endothelial cells) Clinical studies (Dimethyl fumarate, Natalizumab) | Molecular biology, Histopathology, Immunohistochemistry, Behavioral assessments | [10, 26, 157,158,159,160,161,162,163,164,165,166,167,168,169,170,171,172,173] |
Cerebrovascular disease | Reduces oxidative stress after cerebral ischemia and subarachnoid hemorrhage | Upregulation of NQO1 plays a role in facilitating ischemic preconditioning | Nrf2-ARE pathway is activated after subarachnoid hemorrhage (SAH) | Nrf2-ARE-NQO1 pathway contributes to survival of astrocytes and neurons | Experimental studies (Human, rats, mouse tissues) Cell culture studies (Mouse brain microvascular endothelial cells) Clinical studies (Dimethyl fumarate) | Molecular biology, Histopathology, Immunohistochemistry, Behavioral assessments | [95, 174,175,176,177,178,179,180,181,182,183,184,185,186,187,188,189,190,191,192,193,194,195,196,197,198,199,200,201] |
Traumatic Brain Injury | Contribution of oxidative stressgene expression process | Decreased neocortex injury, neutrophil infiltration, and microglia activation | Promoted the nuclear translocation of Nrf2 | As a promising therapeutic strategy | Experimental studies (Human, rats, mouse tissues) Cell culture studies (Mouse brain microvascular endothelial cells) | Molecular biology, Histopathology, Immunohistochemistry, Enzyme assay, Neurobehavioral evaluation | [202,203,204,205,206,207,208,209,210,211,212,213,214,215,216,217,218] |
Epilepsy | Upregulated in hippocampal tissue from individuals with epilepsy | Mitigating epilepsy and associated comorbidities | Reduces apoptosis and pro-inflammatory cytokines in epilepsy model | Protecting against seizures and epilepsy-induced brain damage | Experimental studies (Human, rats, mouse tissues) Cell culture studies (Sprague–Dawley rat mixed cortical neurons and glial cells) | Electrophysiological recordings, Molecular biology, Electron microscopy, Histopathology, Immunohistochemistry, Behavioral evaluation | [89, 113, 219,220,221,222,223,224,225,226,227,228,229,230,231] |
ALS | Protect cells from oxidative stress by detoxifying ROS | Provides neuroprotective effects against neuronal degeneration | Activation of the Nrf2/ARE pathway | Reduce neuronal toxicity | Experimental studies (Human, mouse tissues) Cell culture studies (NSC-34,SOD1-G93A cells) Clinical studies (Fasudil, ferulic acid, caffeic acid,) | Molecular biology, Histopathology, Immunohistochemistry, Behavioral evaluation, Biochemical analysis | [232,233,234,235,236,237,238,239,240,241,242,243,244,245,246,247] |
Brain tumors | Anti-oxidative stress response | Regulating the levels of ROS in glioblastoma | Impact on glioma therapy | Dual role in glioblastoma development | Experimental studies (Human, mouse tissues) Cell culture studies (SH-SY5Y cells, U87MG, LN229 GBM cells,T98G, LN-229,A172,U251 glioma cells) Clinical studies (Prognostic biomarker) | Molecular biology, Immunohistochemistry, Biochemical analysis, Bioinformatic analysis, Enzyme assay | [3, 44, 50, 59, 72, 248,249,250,251,252,253,254,255,256,257,258,259,260,261,262,263,264,265,266,267,268] |